Skip to content

Startup & venture capital news

WhiteLab Genomics raises USD 26m Series B

AVP leads funding for AI-designed genomic medicine assets

By /

LinkedInX
WhiteLab Genomics: WhiteLab Genomics raises USD 26m Series B

WhiteLab Genomics' USD 26 million Series B was first publicly reported on 5 October 2026, with its official announcement following on 6 October. AVP led the round. David Del Bourgo's Paris company applies AI to genomic medicine development, designing delivery-related biological assets and supporting drug developers working on next-generation treatments. Its investment story combines computational tools with the specific needs of a life-sciences development programme. The financing backs a team working on how genomic medicines can be developed and delivered. The announcement date reflects the earliest public coverage, while the official release provides confirmation of the round and its leadership.

Keep reading

More Funding

All stories